Publikationer

Gå direkte til: 

2020

Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes. 
Julsgaard, M., Hvas, C. L., Gearry, R. B., Gibson, P. R., Fallingborg, J., Sparrow, M. P., Bibby, B. M., Connell, W. R., Brown, S. J., Kamm, M. A., Lawrance, I. C., Vestergaard, T., Svenningsen, L., Baekdal, M., Kammerlander, H., Walsh, A., Boysen, T., Bampton, P., Radford-Smith, G., Kjeldsen, J. & 10 flereAndrews, J. M., Subramaniam, K., Moore, G. T., Jensen, N. M., Connor, S. J., Wildt, S., Wilson, B., Ellard, K., Christensen, L. A. & Bell, S. J Inflamm Bowel Dis. 2020 Jan 1;26(1):93-102. 

Authors' Reply to: "COVID-19 in the IBD Population: The Need for Correct Nomenclature."
Attauabi, M., Seidelin, J. B. & Burisch, J., J Crohns Colitis. 2021 Jun 22;15(6):1080

Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease: A Population-Based Danish Cohort Study
Kjærgaard, V. S., Jensen, C. B., Elmahdi, R., Burisch, J., Allin, K. H. & Jess, T., Gastroenterology. 2020 Oct;159(4):1609-1611

Direct and Indirect Costs of Inflammatory Bowel Disease: Ten Years of Follow Up in a Danish Population-Based Inception Cohort.-
Lo, B., Vind, I., Vester-Andersen, M. K., Bendtsen, F. & Burisch, J., Crohns Colitis . 2020 Jan 1;14(1):53-63 

ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment. 
Torres, J., Bonovas, S., Doherty, G., Kucharzik, T., Gisbert, J. P., Raine, T., Adamina, M., Armuzzi, A., Bachmann, O., Bager, P., Biancone, L., Bokemeyer, B., Bossuyt, P., Burisch, J., Collins, P., El-Hussuna, A., Ellul, P., Frei-Lanter, C., Furfaro, F., Gingert, C. & 26 flereGionchetti, P., Gomollon, F., González-Lorenzo, M., Gordon, H., Hlavaty, T., Juillerat, P., Katsanos, K., Kopylov, U., Krustins, E., Lytras, T., Maaser, C., Magro, F., Marshall, J. K., Myrelid, P., Pellino, G., Rosa, I., Sabino, J., Savarino, E., Spinelli, A., Stassen, L., Uzzan, M., Vavricka, S., Verstockt, B., Warusavitarne, J., Zmora, O. & Fiorino, G., J Crohns Colitis . 2020 Jan 1;14(1):4-22.

ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment.
Adamina, M., Bonovas, S., Raine, T., Spinelli, A., Warusavitarne, J., Armuzzi, A., Bachmann, O., Bager, P., Biancone, L., Bokemeyer, B., Bossuyt, P., Burisch, J., Collins, P., Doherty, G., El-Hussuna, A., Ellul, P., Fiorino, G., Frei-Lanter, C., Furfaro, F., Gingert, C. & 26 flereGionchetti, P., Gisbert, J. P., Gomollon, F., Lorenzo, M. G., Gordon, H., Hlavaty, T., Juillerat, P., Katsanos, K., Kopylov, U., Krustins, E., Kucharzik, T., Lytras, T., Maaser, C., Magro, F., Marshall, J. K., Myrelid, P., Pellino, G., Rosa, I., Sabino, J., Savarino, E., Stassen, L., Torres, J., Uzzan, M., Vavricka, S., Verstockt, B. & Zmora, O., J Crohns Colitis. 2020 Feb 10;14(2):155-168

Effect of α-Hemolysin Producing E. coli in Two Different Mouse Strains in a DSS Model of Inflammatory Bowel Disease.
Mirsepasi-Lauridsen, H. C., Struve, C., Petersen, A. M. & Krogfelt, K. A., Microorganisms . 2020 Dec 11;8(12):1971.

Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study.
Attauabi, M., Burisch, J. & Seidelin, J. B., Inflamm Bowel Dis . 2021 Feb 16;27(3):e37-e38

Extraintestinal Manifestations are Associated with Disease Severity in Pediatric Onset Inflammatory Bowel Disease.
Jansson, S., Malham, M., Paerregaard, A., Jakobsen, C. & Wewer, V., J Pediatr Gastroenterol Nutr. 2020 Jul;71(1):40-45

High Abundance of Proteobacteria in Ileo-Anal Pouch Anastomosis and Increased Abundance of Fusobacteria Associated with Increased Pouch Inflammation.
Petersen, A. M., Mirsepasi-Lauridsen, H. C., Vester-Andersen, M. K., Sørensen, N., Krogfelt, K. A. & Bendtsen, F., Antibiotics (Basel). 2020 May 8;9(5):237

Incidence, risk factors and evaluation of osteoporosis in patients with inflammatory bowel disease - a Danish population-based inception cohort with 10 years of follow-up.
Lo, B., Holm, J. P., Vester-Andersen, M. K., Bendtsen, F., Vind, I. & Burisch, J., J Crohns Colitis. 2020 Jul 30;14(7):904-914 

Myeloproliferativ cancer og kronisk inflammatorisk tarmsygdom.
Hesselø, H., Bak, M., Boysen, T., Bytzer, P. & Hasselbalch, H. C., 5 maj 2020, I : Ugeskrift for Laeger. 182, 22 

Outcome of concomitant treatment with thiopurines and allopurinol in patients with inflammatory bowel disease: A nationwide Danish cohort study.
Thomsen, S. B., Allin, K. H., Burisch, J., Jensen, C. B., Hansen, S., Gluud, L. L., Theede, K., Kiszka-Kanowitz, M., Nielsen, A. M. & Jess, T., United European Gastroenterol J . 2020 Feb;8(1):68-76. 

Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy-the Danish IBD Biobank Project: protocol for a multicentre prospective cohort study.
Zhao, M., Bendtsen, F., Petersen, A. M., Larsen, L., Dige, A., Hvas, C., Seidelin, J. B. & Burisch, J., BMJ Open. 2020 Feb 25;10(2):e035756. 

Quality of care standards in inflammatory bowel diseases: a European Crohn's and Colitis Organisation (ECCO) position paper.
Fiorino, G., Lytras, T., Younge, L., Fidalgo, C., Coenen, S., Chaparro, M., Allocca, M., Arnott, I., Bossuyt, P., Burisch, J., Campmans-Kuijpers, M., de Ridder, L., Dignass, A., Drohan, C., Feakins, R., Gilardi, D., Grosek, J., Groß, E., Hart, A., Jäghult, S. & 8 flereKatsanos, K., Lönnfors, S., Panis, Y., Perovic, M., Pierik, M., Rimola, J., Tulchinsky, H. & Gisbert, J. P., J Crohns Colitis. 2020 Sep 7;14(8):1037-1048.

Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases.
Attauabi, M., Zhao, M., Bendtsen, F. & Burisch, J., Inflamm Bowel Dis. 2021 May 17;27(6):927-939

The prevention and management of Crohn's disease postoperative recurrence: results from the Y-ECCO/ClinCom 2019 Survey.
Gabriele Dragoni, Nik Ding, Krisztina B Gecse, John C Mansfield, Uri Kopylov, Laurent Beaugerie, Peter Bossuyt, Shaji Sebastian, Monica Milla, Siro Bagnoli, Nuha A Yassin, Dominik Bettenworth, Johan Burisch, Charlotte Hedin, Javier P Gisbert, Marc Ferrante, Clinical Research Committee (ClinCom) of ECCO and Young ECCO Committee (Y-ECCO), Eur J Gastroenterol Hepatol . 2020 Aug;32(8):1062-1066

Ulcerative Colitis-associated E. coli pathobionts potentiate colitis in susceptible hosts
Yang, H., Mirsepasi-Lauridsen, H. C., Struve, C., Allaire, J. M., Sivignon, A., Vogl, W., Bosman, E. S., Ma, C., Fotovati, A., Reid, G. S., Li, X., Petersen, A. M., Gouin, S. G., Barnich, N., Jacobson, K., Yu, H. B., Krogfelt, K. A. & Vallance, B. A., Gut Microbes. 2020 Nov 9;12(1):1847976 

Validation of ulcerative colitis and Crohn's disease and their phenotypes in the Danish National Patient Registry using a population-based cohort.
Lo, B., Vind, I., Vester-Andersen, M. K. & Burisch, J., 2 okt. 2020, I : Scandinavian Journal of Gastroenterology. 55, 10, s. 1171-1175 5 s.

Viewpoint: Inflammatory bowel diseases among immigrants from low- to high-incidence countries: opportunities and considerations.
Agrawal, M., Burisch, J., Colombel, J-F. & Shah, S. C., Scand J Gastroenterol . 2020 Oct;55(10):1171-1175. 

Efficacy of ustekinumab for active perianal fistulizing Crohn's disease: a systematic review and meta-analysis of the current literature. 
Attauabi, M., Burisch, J. & Seidelin, J. B., Scand J Gastroenterol . 2021 Jan;56(1):53-58 

Global prevalence and bidirectional association between psoriasis and inflammatory bowel disease - A systematic review and meta-analysis.
Alinaghi, F., Tekin, H. G., Burisch, J., Wu, J. J., Thyssen, J. P. & Egeberg, A., J Crohns Colitis. 2020 Mar 13;14(3):351-360

Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis.
Burisch, J., Eigner, W., Schreiber, S., Aletaha, D., Weninger, W., Trauner, M., Reinisch, W. & Narula, N., PLoS One. 2020 May 27;15(5):e0233781

Systematic review of the prevalence and development of osteoporosis or low bone mineral density and its risk factors in patients with inflammatory bowel disease.
Kärnsund, S., Lo, B., Bendtsen, F., Holm, J. & Burisch, J., World J Gastroenterol . 2020 Sep 21;26(35):5362-5374 

The epidemiology of inflammatory bowel disease: East meets West.
Mak, W. Y., Zhao, M., Ng, S. C. & Burisch, J., mar. 2020, I : Journal of Gastroenterology and Hepatology. 35, 3, s. 380-389 10 s.

The risk of extra-intestinal cancer in inflammatory bowel disease: a systematic review and meta-analysis of population-based cohort studies.
Lo, B., Zhao, M., Vind, I. & Burisch, J., Clin Gastroenterol Hepatol . 2021 Jun;19(6):1117-1138 

The Sooner the Better? Cost-effectiveness of Early Biological Therapy in Patients With Crohn's Disease.
Zhao, M. & Burisch, J., J Crohns Colitis. 2020 Jun 19;14(5):573-574

2019

A 10-Year Follow-up Study of the Natural History of Perianal Crohn's Disease in a Danish Population-Based Inception Cohort.
Zhao, M., Lo, B. Z. S., Vester-Andersen, M. K., Vind, I., Bendtsen, F. & Burisch, J., 18 jun. 2019, I : Inflammatory Bowel Diseases. 25, 7, s. 1227-1236 10 s.

Adalimumab in the treatment of chronic pouchitis. A randomized double-blind, placebo-controlled trial.
Kjær, M. D., Qvist, N., Nordgaard-Lassen, I., Christensen, L. A. & Kjeldsen, J., feb. 2019, I: Scandinavian Journal of Gastroenterology. 54, 2, s. 188-193 6 s.

Challenges and obstacles in the transition process through the eyes of the gastroenterologist.
Hald, M., Carlsen, K., Nordgaard-Lassen, I. & Wewer, V., apr. 2019, I : European journal of gastroenterology & hepatology. 31, 4, s. 486-493 8 s.

Changing epidemiology of immune-mediated inflammatory diseases in immigrants: A systematic review of population-based studies.
Agrawal, M., Shah, S., Patel, A., Pinotti, R., Colombel, J-F. & Burisch, J., dec. 2019, I : Journal of Autoimmunity. 105, 102303. 

Editorial: suicide and IBD-a call to action. Authors' reply
Malham, M., Jakobsen, C., Hald, M., Paerregaard, A., Virta, L. J., Kolho, K-L. & Wewer, V., jul. 2019, I : Alimentary Pharmacology and Therapeutics. 50, 1, s. 106-107 2 s. 

Health-related quality of life in inflammatory bowel disease in a Danish population-based inception cohort.
Christiansen, L. K., Lo, B., Bendtsen, F., Vind, I., Vester-Andersen, M. K. & Burisch, J., aug. 2019, I : United European Gastroenterology Journal. 7, 7, s. 942-954 13 s.

Increased abundance of proteobacteria in aggressive Crohn's disease seven years after diagnosis.
Vester-Andersen, M. K., Mirsepasi-Lauridsen, H. C., Prosberg, M. V., Mortensen, C. O., Träger, C., Skovsen, K., Thorkilgaard, T., Nøjgaard, C., Vind, I., Krogfelt, K. A., Sørensen, N., Bendtsen, F. & Petersen, A. M., 17 sep. 2019, I : Scientific Reports. 9, 13473. 

Outcome of concomitant treatment with thiopurines and allopurinol in patients with inflammatory bowel disease: A nationwide Danish cohort study
Thomsen, S. B., Allin, K. H., Burisch, J., Jensen, C. B., Hansen, S., Gluud, L. L., Theede, K., Kiszka-Kanowitz, M., Nielsen, A. M. & Jess, T., 1 jan. 2019, I : United European Gastroenterology Journal.

Paediatric onset inflammatory bowel disease is a distinct and aggressive phenotype - a comparative population-based study.
Knudsen, M. M., Jakobsen, C., Vester-Andersen, M. K., Zhao Sheng Lo, B., Pærregaard, A., Vind, I. & Wewer, A. V., 2019, I : GastroHep.. 1, 6, s. 266-273 8 s.

Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative Colitis.
Malham, M., Carlsen, K., Riis, L., Paerregaard, A., Vind, I., Fenger, M. & Wewer, V., okt. 2019, I : Scandinavian Journal of Gastroenterology. 54, 10, s. 1214-1219 6 s.

Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel disease.
Danish IBD Genetics Working Group, apr. 2019, I : Alimentary Pharmacology and Therapeutics. 49, 7, s. 890-903 14 s.

The incidence of cancer and mortality in paediatric onset inflammatory bowel disease in Denmark and Finland during a 23-year period: a population-based study.
Malham, M., Jakobsen, C., Paerregaard, A., Virta, L. J., Kolho, K-L. & Wewer, V., jul. 2019, I : Alimentary Pharmacology and Therapeutics. 50, 1, s. 33-39 7 s.

The microbiome reflects diagnosis and predicts disease severity in paediatric onset inflammatory bowel disease.
Malham, M., Lilje, B., Houen, G., Winther, K., Andersen, P. S. & Jakobsen, C., aug. 2019, I : Scandinavian Journal of Gastroenterology. 54, 8, s. 969-975 7 s.

Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development.
King, J. A., Underwood, F. E., Panaccione, N., Quan, J., Windsor, J. W., Kotze, P. G., Ng, S. C., Ghosh, S., Lakatos, P. L., Jess, T., Panaccione, R., Seow, C. H., Ben-Horin, S., Burisch, J., Colombel, J-F., Loftus, E. V., Gearry, R., Halfvarson, J. & Kaplan, G. G., 1 apr. 2019, I : The Lancet Gastroenterology and Hepatology. 4, 4, s. 287-295 9 s.

Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease
Mirsepasi-Lauridsen, H. C., Vallance, B. A., Krogfelt, K. A. & Petersen, A. M., 20 mar. 2019, I : Clinical Microbiology Reviews. 32, 2, e00060-18. 

Impact of Genes and the Environment on the Pathogenesis and Disease Course of Inflammatory Bowel Disease.
Zhao, M. & Burisch, J., jul. 2019, I : Digestive Diseases and Sciences. 64, 7, s. 1759-1769 11 s.

Long-term Outcomes of Paediatric Patients Admitted With Acute Severe Colitis- A Multicentre Study From the Paediatric IBD Porto Group of ESPGHAN.
Krauthammer A, Tzivinikos C, Assa A, Miele E, Strisciuglio C, Urlep D, Serban ED, Singh A, Winter HS, Russell RK, Hojsak I, Malham M, Navas-López VM, Croft NM, Lee HM, Ledder O, Shamasneh I, Hussey S, Huynh HQ, Wine E, Shah N, Sladek M, de Meij TG, Romano C, Dipasquale V, Lionetti P, Afzal NA, Aloi M, Lee K, Martín-de-Carpi J, Yerushalmy-Feler A, Subramanian S, Weiss B, Shouval DS. J Crohns Colitis. 2019 Dec 10;13(12):1518-1526. doi: 10.1093/ecco-jcc/jjz092. PubMed PMID: 31120524.

Head to head comparison of two commercial fecal calprotectin kits as predictor of Mayo endoscopic sub-score and mucosal TNF expression in ulcerative colitis. 
Goll R, Heitmann R, Moe ØK, Carlsen K, Florholmen J. PLoS One. 2019 Dec 2;14(12):e0224895. doi: 10.1371/journal.pone.0224895. eCollection 2019. PubMed PMID: 31790426; PubMed Central PMCID: PMC6886764.

Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative Colitis.
Malham M, Carlsen K, Riis L, Paerregaard A, Vind I, Fenger M, Wewer V. Scand J Gastroenterol. 2019 Oct;54(10):1214-1219. doi: 10.1080/00365521.2019.1665097. Epub 2019 Sep 17. PubMed PMID: 31526273.

The microbiome reflects diagnosis and predicts disease severity in paediatric onset inflammatory bowel disease.
Malham M, Lilje B, Houen G, Winther K, Andersen PS, Jakobsen C.  Scand J Gastroenterol. 2019 Aug;54(8):969-975. doi: 10.1080/00365521.2019.1644368. Epub 2019 Jul 22. PubMed PMID: 31329473.

Editorial: suicide and IBD-a call to action. Authors' reply.
Malham M, Jakobsen C, Hald M, Paerregaard A, Virta LJ, Kolho KL, Wewer V. Aliment Pharmacol
Ther. 2019 Jul;50(1):106-107. doi: 10.1111/apt.15318. PubMed PMID: 31184387. 

The incidence of cancer and mortality in paediatric onset inflammatory bowel disease in Denmark and Finland during a 23-year period: a population-based study.
Malham M, Jakobsen C, Paerregaard A, Virta LJ, Kolho KL, Wewer V. Aliment Pharmacol Ther. 2019 Jul;50(1):33-39. doi: 10.1111/apt.15258. Epub 2019 May 8. PubMed PMID: 31069829.

Coping Among Parents of Teens With Inflammatory Bowel Disease.
Carlsen K, Phan BL, Pittman N, Benkov K, Dubinsky MC, Keefer L. Gastroenterol Nurs. 2019 Jul/Aug;42(4):342-350. doi: 10.1097/SGA.0000000000000374. PubMed PMID: 31365424.

Serum Calprotectin in Adolescents With Inflammatory Bowel Disease-A Pilot Investigation.
Carlsen K, Malham M, Hansen LF, Petersen JJH, Paerregaard A, Houen G, Wewer V. J Pediatr Gastroenterol Nutr. 2019 May;68(5):669-675. doi: 10.1097/MPG.0000000000002244. PubMed PMID: 30628981.

A Personalized eHealth Transition Concept for Adolescents With Inflammatory Bowel Disease: Design of Intervention.
Carlsen K, Hald M, Dubinsky MC, Keefer L, Wewer V. JMIR Pediatr Parent. 2019 Apr 24;2(1):e12258. doi: 10.2196/12258. PubMed PMID: 31518331; PubMed Central PMCID: PMC6715343. 

Biochemical Markers, Genotype, and Inflammation in Pediatric Inflammatory Bowel Disease: A Danish Population-Based Study.
Ziade F, Rungoe C, Kallemose T, Paerregaard A, Wewer AV, Jakobsen C. Dig Dis. 2019;37(2):140-146. doi:10.1159/000494215. Epub 2018 Nov 13. PubMed PMID: 30423580.

2018

Changes in Disease Behaviour and Location in Patients With Crohn's Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort
Lo, B., Vester-Andersen, M. K., Vind, I., Prosberg, M., Dubinsky, M., Siegel, C. A., Bendtsen, F. & Burisch, J. 1 maj 2018 I : Journal of Crohn's & colitis. 12, 3, s. 265-272. 

Characterization of the enhancer and promoter landscape of inflammatory bowel disease from human colon biopsies.
Boyd, M. , Thodberg, M. , Vitezic, M. , Bornholdt, J. , Vitting-Seerup, K. , Chen, Y. , Coskun, M. , Li, Y. , Lo, B. Z. S. , Klausen, P. , Jan Schweiger, P. , Pedersen, A. G. , Rapin, N. , Skovgaard, K. , Dahlgaard, K. , Andersson, R. , Terkelsen, T. B. , Lilje, B. , Troelsen, J. T. , Petersen, A. M. & 6 flere Jensen, K. B., Gögenur, I., Thielsen, P., Seidelin, J. B., Nielsen, O. H. & Sandelin, A. 1 apr. 2018 I : Nature Communications. 9, 1661

Disease activity, steroid use and extraintestinal manifestation are associated with increased disability in patients with inflammatory bowel disease using the inflammatory bowel disease disability index: a cross-sectional multicentre cohort study.
Lo, B., Julsgaard, M., Vester-Andersen, M. K., Vind, I. & Burisch, J. 1 sep. 2018 I : European journal of gastroenterology & hepatology. 30, 10, s. 1130-1136

Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease.
Mirsepasi-Lauridsen, H. C., Vrankx, K., Engberg, J., Friis-Møller, A., Brynskov, J., Nordgaard-Lassen, I., Petersen, A. M. & Krogfelt, K. A. 2018 I : Frontiers in medicine. 5, s. 304 

Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy
Bank, S., Andersen, P. S., Burisch, J., Pedersen, N., Roug, S., Galsgaard, J., Turino, S. Y., Brodersen, J. B., Rashid, S., Rasmussen, B. K., Avlund, S., Olesen, T. B., Hoffmann, H. J., Nexø, B. A., Sode, J., Vogel, U. & Andersen, V. 2018 I : The pharmacogenomics journal. 18, 1, s. 87-97 

Optimized thiopurine therapy before withdrawal of anti-tumour necrosis factor-α in patients with Crohn's disease
Bohn Thomsen, S., Kiszka-Kanowitz, M., Theede, K., Gluud, L. L. & Mertz Nielsen, A. 1 sep. 2018 I : European journal of gastroenterology & hepatology. 30, 10, s. 1155-1158

Point of care testing of fecal calprotectin as a substitute for routine laboratory analysis
Hejl, J., Theede, K., Møllgren, B., Madsen, K. V., Heidari, A., Á Steig, A. & Fenger, M. mar. 2018 I : Practical Laboratory Medicine. 10, s. 10-14

Review of Saccharomyces boulardii as a treatment option in IBD
Sivananthan, K. & Petersen, A. M. jun. 2018 I : Immunopharmacology and Immunotoxicology. 17, s. 1-11 

Systematic review and meta-analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index
Lo, B., Prosberg, M. V., Gluud, L. L., Chan, D. W., Leong, R. W., van der List, E., van der Have, M., Sarter, H., Gower-Rousseau, C., Peyrin-Biroulet, L., Vind, I. & Burisch, J. 1 jan. 2018 I : Alimentary Pharmacology and Therapeutics. 47, 1, s. 6-15

Validation of the "United Registries for Clinical Assessment and Research" (UR-CARE), a European online registry for clinical care and research in Inflammatory Bowel Disease.
Burisch, J. , Gisbert, J. P. , Siegmund, B. , Bettenworth, D. , Bohn Thomsen, S. , Cleynen, I. , Cremer, A. , Ding, N. J. S. , Furfaro, F. , Galanopoulos, M. , Grunert, P. C. , Hanzel, J. , Knezevic Ivanovski, T. , Krustins, E. , Noor, N. , O'Morain, N. , Rodríguez-Lago, I. , Scharl, M. , Tua, J. , Uzzan, M. & 3 flere Yassin, N. A., Baert, F. & Langholz, E. 1 maj 2018 I : Journal of Crohn's & colitis. 12, 5, s. 532-537

Response to treatment is more important than disease severity at diagnosis for prediction of early relapse in new-onset paediatric Crohn's disease.
Ziv-Baran T, Hussey S, Sladek M, Amil Dias J, Martin de Carpi J, Miele E, Veres G, Lionetti P, Koletzko S, Nuti F, Paerregaard A, Kolho KL, Russell RK, Shaoul R, Weiner D, Sigall Boneh R, Escher J, Finnby L, Turner D, Levine A. Aliment Pharmacol Ther. 2018 Dec;48(11-12):1242-1250. doi: 10.1111/apt.15016. Epub 2018.

Nov 18. PubMed PMID: 30450578.

Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study
Chetcuti Zammit S, Ellul P, Girardin G, Valpiani D, Nielsen KR, Olsen J, Goldis A, Lazar D, Shonová O, Nováková M, Sebastian S, Whitehead E, Carmona A, Martinez-Cadilla J, Dahlerup JF, Kievit ALH, Thorsgaard N, Katsanos KH, Christodoulou DK, Magro F, Salupere R, Pedersen N, Kjeldsen J, Carlsen K, Ioannis K, Bergemalm D, Halfvarson J, Duricova D, Bortlik M, Collin P, Oksanen P, Kiudelis G, Kupcinskas L, Kudsk K, Andersen V, O'Morain C, Bailey Y, Doron S, Shmuel O, Almer S, Arebi N, Misra R, Čuković-Čavka S, Brinar M, Munkholm P, Vegh Z, Burisch J. Eur J Gastroenterol Hepatol. 2018 Nov;30(11):1297-1303. doi: 10.1097/MEG.0000000000001238. PubMed PMID: 30134383.

Børn og unge med funktionelle abdominalproblemer har brug for nye behandlingstilbud.
Teilmann G, Pærregaard A. Ugeskr Laeger. 2018 Sep 17;180(38). pii:
V69860. Danish. PubMed PMID: 30259836.

Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN.
Joosse ME, Aardoom MA, Kemos P, Turner D, Wilson DC, Koletzko S, Martin-de-Carpi J, Fagerberg UL, Spray C, Tzivinikos C, Sladek M, Shaoul R, Roma-Giannikou E, Bronsky J, Serban DE, Ruemmele FM, Garnier-Lengline H, Veres G, Hojsak I, Kolho KL, Davies IH, Aloi M, Lionetti P, Hussey S, Veereman G, Braegger CP, Trindade E, Wewer AV, Hauer AC, de Vries ACH, Sigall Boneh R, Sarbagili Shabat C, Levine A, de Ridder L; Paediatric IBD Porto group of ESPGHAN. Aliment Pharmacol Ther. 2018 Sep;48(5):523-537. doi: 10.1111/apt.14893. Epub 2018 Jul 8. PubMed PMID: 29984520.

Diagnostic Yield of Next-generation Sequencing in Very Early-onset Inflammatory Bowel Diseases: A Multicentre Study.
Charbit-Henrion F, Parlato M, Hanein S, Duclaux-Loras R, Nowak J, Begue B, Rakotobe S, Bruneau J, Fourrage C, Alibeu O, Rieux-Laucat F, Lévy E, Stolzenberg MC, Mazerolles F, Latour S, Lenoir C, Fischer A, Picard C, Aloi M, Dias JA, Hariz MB, Bourrier A, Breuer C, Breton A, Bronski J, Buderus S, Cananzi M, Coopman S, Crémilleux C, Dabadie A, Dumant-Forest C, Gurkan OE, Fabre A, Fischer A, Diaz MG, Gonzalez-Lama Y, Goulet O, Guariso G, Gurcan N, Homan M, Hugot JP, Jeziorski E, Karanika E, Lachaux A, Lewindon P, Lima R, Magro F, Major J, Malamut G, Mas E, Mattyus I, Mearin LM, Melek J, Navas-Lopez VM, Paerregaard A, Pelatan C, Pigneur B, Pais IP, Rebeuh J, Romano C, Siala N, Strisciuglio C, Tempia-Caliera M, Tounian P, Turner D, Urbonas V, Willot S, Ruemmele FM, Cerf-Bensussan N. J Crohns Colitis. 2018 Aug 29;12(9):1104-1112. doi: 10.1093/ecco-jcc/jjy068. PubMed PMID: 29788237; PubMed Central PMCID: PMC6113703.

Corrigendum: Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN.
Ledder O, Assa A, Levine A, Escher JC, de Ridder L, Ruemmele F, Shah N, Shaoul R, Wolters VM, Rodrigues A, Uhlig HH, Posovszky C, Kolho KL, Jakobsen C, Cohen S, Shouval DS, de Meij T, Martin-de-Carpi J, Richmond L, Bronsky J, Friedman M, Turner D.

J Crohns Colitis. 2018 Apr 27;12(5):630. doi: 10.1093/ecco-jcc/jjx172. PubMed PMID: 29562246.

A new mutation in the C-terminal end of TTC37 leading to a mild form of syndromic diarrhea/tricho-hepato-enteric syndrome in seven patients from two families.
Fabre A, Petit LM, Hansen LF, Wewer AV, Esteve C, Chaix C, Bourgeois P, Badens C, Paerregaard A. Am J Med Genet A. 2018 Mar;176(3):727-732. doi: 10.1002/ajmg.a.38618. Epub 2018 Jan 31. PubMed PMID: 29383842.

Differences in Outcomes Over Time With Exclusive Enteral Nutrition Compared With Steroids in Children With Mild to Moderate Crohn's Disease: Results From the GROWTH CD Study.
Cohen-Dolev N, Sladek M, Hussey S, Turner D, Veres G, Koletzko S, Martin de Carpi J, Staiano A, Shaoul R, Lionetti P, Amil Dias J, Paerregaard A, Nuti F, Pfeffer Gik T, Ziv-Baran T, Ben Avraham Shulman S, Sarbagili Shabat C, Sigall Boneh R, Russell RK, Levine A. J Crohns Colitis. 2018 Feb 28;12(3):306-312. doi: 10.1093/ecco-jcc/jjx150. PubMed PMID: 29165666. 

The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis. 
Carlsen K, Riis LB, Elsberg H, Maagaard L, Thorkilgaard T, Sørbye SW, Jakobsen C, Wewer V, Florholmen J, Goll R, Munkholm P. Scand J Gastroenterol. 2018 Jun - Jul;53(7):825-830. doi: 10.1080/00365521.2018.1482956. Epub 2018 Jul 3. PubMed PMID: 29968483.

F-calprotectin and Blood Markers Correlate to Quality of Life in Pediatric Inflammatory Bowel Disease.
Carlsen K, Jakobsen C, Kallemose T, Paerregaard A, Riis LB, Munkholm P, Wewer V. J Pediatr Gastroenterol Nutr. 2017 Nov;65(5):539-545. doi: 10.1097/MPG.0000000000001540. PubMed PMID: 28169974.

Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN.
Ledder O, Assa A, Levine A, Escher JC, de Ridder L, Ruemmele F, Shah N, Shaoul R, Wolters VM, Rodrigues A, Uhlig HH, Posovszky C, Kolho KL, Jakobsen C, Cohen S, Shouval DS, de Meij T, Martin-de-Carpi J, Richmond L, Bronsky J, Friedman M, Turner D. J Crohns Colitis. 2017 Oct 1;11(10):1230-1237. doi: 10.1093/ecco-jcc/jjx082. Erratum in: J Crohns Colitis. 2018 Apr 27;12(5):630. PubMed PMID: 28605483. 

2017

A randomised, double-blind, placebo-controlled trial of Trichuris suis ova (TSO) in active Crohn's disease
Schölmerich, J., Fellermann, K., Seibold, F. W., Rogler, G., Langhorst, J., Howaldt, S., Novacek, G., Petersen, A. M., Bachmann, O., Matthes, H., Hesselbarth, N., Teich, N., Wehkamp, J., Klaus, J., Ott, C., Dilger, K., Greinwald, R., Mueller, R. & International TRUST-2 Study Group apr. 2017 I : Journal of Crohn's & colitis. 11, 4, s. 390-399

Anti-NKG2D mAb: A New Treatment for Crohn's Disease?
Vadstrup, K. & Bendtsen, F. 1 sep. 2017 I : International Journal of Molecular Sciences. 18, 9

Defining success in treating patients with inflammatory bowel disease

Theede, K. & Burisch, J. 2017 I : Expert Review of Clinical Immunology. 13, 7, s. 645-647

NKG2D ligand expression in Crohn's disease and NKG2D-dependent stimulation of CD8(+) T cell migration. 
Vadstrup, K., Galsgaard, E. D., Jensen, H., Lanier, L. L., Ryan, J. C., Chen, S-Y., Nolan, G. P., Vester-Andersen, M. K., Pedersen, J. S., Gerwien, J., Jensen, T. & Bendtsen, F. 1 aug. 2017 I : Experimental and Molecular Pathology. 103, 1, s. 56-70

Occurrence of anaemia in the first year of inflammatory bowel disease in a European population-based inception cohort - An ECCO-EpiCom study.
Burisch, J. , Vegh, Z. , Katsanos, K. H. , Christodoulou, D. K. , Lazar, D. , Goldis, A. , O'Morain, C. , Fernandez, A. , Pereira, S. , Myers, S. , Sebastian, S. , Pedersen, N. , Olsen, J. , Nielsen, K. R. , Schwartz, D. , Odes, S. , Almer, S. , Halfvarson, J. , Turk, N. , Cukovic-Cavka, S. & 33 flere Nikulina, I., Belousova, E., Duricova, D., Bortlik, M., Shonová, O., Salupere, R., Barros, L., Magro, F., Jonaitis, L., Kupcinskas, L., Turcan, S., Kaimakliotis, I., Ladefoged, K., Kudsk, K., Andersen, V., Vind, I., Thorsgaard, N., Oksanen, P., Collin, P., Dal Piaz, G., Santini, A., Niewiadomski, O., Bell, S., Moum, B., Arebi, N., Kjeldsen, J., Carlsen, K., Langholz, E., Lakatos, P. L., Munkholm, P., Gerdes, L. U., Dahlerup, J. F. & EpiCom study group 1 okt. 2017 I : Journal of Crohn's & colitis. 11, 10, s. 1213-1222

Proximal disease extension in patients with limited ulcerative colitis: a Danish population-based inception cohort.
Burisch, J., Ungaro, R., Vind, I., Prosberg, M. V., Bendtsen, F., Colombel, J. F. & Vester-Andersen, M. K. 1 okt. 2017 I : Journal of Crohn's & colitis. 11, 10, s. 1200-1204

Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort-An ECCO-EpiCom Study.
Burisch J, Vegh Z, Katsanos KH, Christodoulou DK, Lazar D, Goldis A, O'Morain C, Fernandez A, Pereira S, Myers S, Sebastian S, Pedersen N, Olse J, Rubek Nielsen K, Schwartz D, Odes S, Almer S, Halfvarson J, Turk N, Cukovic-Cavka S, Nikulina I, Belousova E, Duricova D, Bortlik M, Shonová O, Salupere R, Barros L, Magro F, Jonaitis L, Kupcinskas L, Turcan S, Kaimakliotis I, Ladefoged K, Kudsk K, Andersen V, Vind I, Thorsgaard N, Oksanen P, Collin P, Dal Piaz G, Santini A, Niewiadomski O, Bell S, Moum B, Arebi N, Kjeldsen J, Carlsen K, Langholz E, Lakatos PL, Munkholm P, Gerdes LU, Dahlerup JF; EpiCom study group. J Crohns Colitis. 2017 Oct 1;11(10):1213-1222. doi: 10.1093/ecco-jcc/jjx077. PubMed PMID: 28575481. 

Individualized Infliximab Treatment Guided by Patient-managed eHealth in Children and Adolescents with Inflammatory Bowel Disease.
Carlsen K, Houen G, Jakobsen C, Kallemose T, Paerregaard A, Riis LB, Munkholm P, Wewer V. Inflamm Bowel Dis. 2017 Sep;23(9):1473-1482. doi: 10.1097/MIB.0000000000001170. PubMed PMID: 28617758. 

Development and Validation of Diagnostic Criteria for IBD Subtypes Including IBD-unclassified in Children: a Multicentre Study From the Pediatric IBD Porto Group of ESPGHAN
Birimberg-Schwartz L, Zucker DM, Akriv A, Cucchiara S, Cameron FL, Wilson DC, Lazowska I, Yianni L, Paul SP, Romano C, Kolacek S, Buderus S, Pærregaard A, Russell RK, Escher JC, Turner D; Pediatric IBD Porto group of ESPGHAN. J Crohns Colitis. 2017 Sep 1;11(9):1078-1084. doi:10.1093/ecco-jcc/jjx053. PubMed PMID: 28430891. 

European Crohn's and Colitis Organisation Topical Review on Transitional Care in Inflammatory Bowel Disease.
van Rheenen PF, Aloi M, Biron IA, Carlsen K, Cooney R, Cucchiara S, Cullen G, Escher JC, Kierkus J, Lindsay JO, Roma E, Russell RK, Sieczkowska-Golub J, Harbord M. J Crohns Colitis. 2017 Sep 1;11(9):1032-1038. doi: 10.1093/ecco-jcc/jjx010. PubMed PMID: 28158494. 

[Gluten-free diet is for some a necessity, for others a lifestyle].
Jønsson IM, Møller GL, Pærregaard A.  Ugeskr Laeger. 2017 May 29;179(22). pii: V09160636. Review. Danish. PubMed PMID: 28553923. 

Surgical Management of Crohn Disease in Children: Guidelines From the Paediatric IBD Porto Group of ESPGHAN.
Amil-Dias J, Kolacek S, Turner D, Pærregaard A, Rintala R, Afzal NA, Karolewska-Bochenek K, Bronsky J, Chong S, Fell J, Hojsak I, Hugot JP, Koletzko S, Kumar D, Lazowska-Przeorek I, Lillehei C, Lionetti P, Martin-de-Carpi J, Pakarinen M, Ruemmele FM, Shaoul R, Spray C, Staiano A, Sugarman I, Wilson DC, Winter H, Kolho KL; IBD Working Group of ESPGHAN (IBD Porto Group).  J Pediatr Gastroenterol Nutr. 2017 May;64(5):818-835. doi: 10.1097/MPG.0000000000001562. PubMed PMID: 28267075.

Self-managed eHealth Disease Monitoring in Children and Adolescents with Inflammatory Bowel Disease: A Randomized Controlled Trial.

Carlsen K, Jakobsen C, Houen G, Kallemose T, Paerregaard A, Riis LB, Munkholm P, Wewer V. Inflamm Bowel Dis. 2017 Mar;23(3):357-365. doi: 10.1097/MIB.0000000000001026. PubMed PMID: 28221247.

Self-efficacy and Resilience Are Useful Predictors of Transition Readiness Scores in Adolescents with Inflammatory Bowel Diseases.
Carlsen K, Haddad N, Gordon J, Phan BL, Pittman N, Benkov K, Dubinsky MC, Keefer L. Inflamm Bowel Dis. 2017 Mar;23(3):341-346. doi: 10.1097/MIB.0000000000001038. PubMed PMID: 28178002.

Using eHealth strategies in delivering dietary and other therapies in patients with irritable bowel syndrome and inflammatory bowel disease.
Ankersen DV, Carlsen K, Marker D, Munkholm P, Burisch J. J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:27-31. doi: 10.1111/jgh.13691. Review. PubMed PMID: 28244677. 

[Lactose malabsorption and -intolerance - who will benefit from a lactose-reduced diet?].
Malham M, Olin AB, Pærregaard A. Ugeskr Laeger. 2017 Feb 6;179(6). pii: V09160627. Review. Danish. PubMed PMID: 28397685.

2016

A randomised, double-blind, placebo-controlled trial of Trichuris suis ova (TSO) in active Crohn's disease
Schölmerich, J., Fellermann, K., Seibold, F. W., Rogler, G., Langhorst, J., Howaldt, S., Novacek, G., Petersen, A. M., Bachmann, O., Matthes, H., Hesselbarth, N., Teich, N., Wehkamp, J., Klaus, J., Ott, C., Dilger, K., Greinwald, R., Mueller, R. & International TRUST-2 Study Group 5 okt. 2016 I : Journal of Crohn's & colitis. 

Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis
Mirsepasi-Lauridsen, H. C., Halkjaer, S. I., Mortensen, E. M., Lydolph, M. C., Nordgaard-Lassen, I., Krogfelt, K. A. & Petersen, A. M. 1 okt. 2016 I : Scientific Reports. 6, s. 31152

Fecal Calprotectin Measured By Patients at Home Using Smartphones-A New Clinical Tool in Monitoring Patients with Inflammatory Bowel Disease
Vinding, K. K., Højgaard Elsberg , H., Thorkilgaard, T., Belard, E., Pedersen, N., Elkjaer, M., Marker, D., Carlsen, K., Burisch, J. & Munkholm, P. 2016 I : Inflammatory bowel diseases. 22, 2, s. 336-44 

Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis Theede, K., Holck, S., Ibsen, P., Kallemose, T., Nordgaard-Lassen, I. & Nielsen, A. M. 2016 I : Inflammatory bowel diseases.

Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet
Louise Maagaard, Dorit V Ankersen, Zsuzsanna Végh, Johan Burisch, Lisbeth Jensen, Natalia Pedersen, Pia Munkholm. World J Gastroenterol . 2016 Apr 21;22(15):4009-19. doi: 10.3748/wjg.v22.i15.4009.

Long-term Compliance with Oral 5-aminosalicylic Acid Therapy and Risk of Disease Recurrence in Patients with Ulcerative Colitis: A Population-based Cohort Study
Prosberg, M. V., Vester-Andersen, M. K., Andersson, M., Jess, T., Andersen, J. T., Vind, I. & Bendtsen, F. apr. 2016 I : Inflammatory bowel diseases. 22, 4, s. 925-932

Randomized clinical trial: a pilot study comparing efficacy of low-dose azathioprine and allopurinol to azathioprine on clinical outcomes in inflammatory bowel disease
Kiszka-Kanowitz, M., Theede, K. & Mertz-Nielsen, A. dec. 2016 I : Scandinavian journal of gastroenterology. 51, 12, s. 1470-1475 6 s.

Secretion of Alpha-Hemolysin by Escherichia coli Disrupts Tight Junctions in Ulcerative Colitis Patients
Mirsepasi-Lauridsen, H. C., Du, Z., Struve, C., Charbon, G., Karczewski, J., Krogfelt, K. A., Petersen, A. M. & Wells, J. M. 2016 I : Clinical and Translational Gastroenterology. 7, s. e149

The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis
Prosberg, M., Bendtsen, F., Vind, I., Petersen, A. M. & Gluud, L. L. nov. 2016 I : Scandinavian journal of gastroenterology. 51, 12

The Danish National Registry for Biological Therapy in Inflammatory Bowel Disease
Larsen, L., Jensen, M. D., Larsen, M. D., Nielsen, R. G., Thorsgaard, N., Vind, I., Wildt, S. & Kjeldsen, J. 1 okt. 2016 I : Clinical Epidemiology. 8, s. 607-612

The First European Evidence-Based Consensus on Extra-Intestinal Manifestations in Inflammatory Bowel Disease
Harbord, M. , Annese, V. , Vavricka, S. R. , Allez, M. , Barreiro-de Acosta, M. , Borberg, K. , Burisch, J. , De Vos, M. , De Vries, A-M. , Dick, A. D. , Juillerat, P. , Karlsen, T. , Koutroubakis, I. , Lakatos, P. , Orchard, T. , Papay, P. , Raine, T. , Reinshagen, M. , Thaçi, D. , Tilg, H. & 2 flere Carbonnel, F. & European Crohn's and Colitis Organisation (ECCO) nov. 2016 I : Journal of Crohn's & colitis.

Hollow-core fibers for high power pulse delivery.
Michieletto M, Lyngsø JK, Jakobsen C, Lægsgaard J, Bang O, Alkeskjold TT. Opt Express. 2016 Apr 4;24(7):7103-19. doi: 10.1364/OE.24.007103. PubMed PMID: 27137004. 

Perinatal vitamin D levels are not associated with later risk of developing pediatric-onset inflammatory bowel disease: a Danish case-cohort study.
Thorsen SU, Jakobsen C, Cohen A, Lundqvist M, Thygesen LC, Pipper C, Ascherio

A, Svensson J. Scand J Gastroenterol. 2016 Aug;51(8):927-33. doi: 10.3109/00365521.2016.1144218. Epub 2016 Feb 12. PubMed PMID: 26872831.

High energy supercontinuum sources using tapered photonic crystal fibers for multispectral photoacoustic microscopy. 
Bondu M, Brooks C, Jakobsen C, Oakes K, Moselund PM, Leick L, Bang O, Podoleanu A. J Biomed Opt. 2016 Jun;21(6):61005. doi: 10.1117/1.JBO.21.6.061005. PubMed PMID: 26836298.

Efficacy and safety of granulocyte, monocyte/macrophage adsorptive in pediatric ulcerative colitis.
Ruuska T, Küster P, Grahnquist L, Lindgren F, Wewer AV.
World J Gastroenterol. 2016 May 7;22(17):4389-96. doi: 10.3748/wjg.v22.i17.4389.

PubMed PMID: 27158208; PubMed Central PMCID: PMC4853697. 

Ph.d.-afhandlinger

Development of an explant assay for assessment of Crohn's disease in combination with investigations of the therapeutic target of NKG2D

Vadstrup, K.201648 s.

The role of fecal calprotectin in ulcerative colitis
Theede, K.4 mar. 201653 s.

Redaktør